Comparison Overview

Vertex Pharmaceuticals

VS

The National Institutes of Health

Vertex Pharmaceuticals

Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, US, 02210
Last Update: 2025-11-26
View Profile
Between 750 and 799
https://www.vrtx.com/

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 6,124
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

The National Institutes of Health

9000 Rockville Pike, Bethesda, MD, US, 20892
Last Update: 2025-11-27
Between 750 and 799
http://www.nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 29,850
Subsidiaries: 50
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/vertex-pharmaceuticals.jpeg
Vertex Pharmaceuticals
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/national-institutes-of-health.jpeg
The National Institutes of Health
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Vertex Pharmaceuticals
100%
Compliance Rate
0/4 Standards Verified
The National Institutes of Health
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Vertex Pharmaceuticals in 2025.

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for The National Institutes of Health in 2025.

Incident History — Vertex Pharmaceuticals (X = Date, Y = Severity)

Vertex Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries

Incident History — The National Institutes of Health (X = Date, Y = Severity)

The National Institutes of Health cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/vertex-pharmaceuticals.jpeg
Vertex Pharmaceuticals
Incidents

No Incident

https://images.rankiteo.com/companyimages/national-institutes-of-health.jpeg
The National Institutes of Health
Incidents

No Incident

FAQ

The National Institutes of Health company demonstrates a stronger AI Cybersecurity Score compared to Vertex Pharmaceuticals company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, The National Institutes of Health company has disclosed a higher number of cyber incidents compared to Vertex Pharmaceuticals company.

In the current year, The National Institutes of Health company and Vertex Pharmaceuticals company have not reported any cyber incidents.

Neither The National Institutes of Health company nor Vertex Pharmaceuticals company has reported experiencing a ransomware attack publicly.

Neither The National Institutes of Health company nor Vertex Pharmaceuticals company has reported experiencing a data breach publicly.

Neither The National Institutes of Health company nor Vertex Pharmaceuticals company has reported experiencing targeted cyberattacks publicly.

Neither Vertex Pharmaceuticals company nor The National Institutes of Health company has reported experiencing or disclosing vulnerabilities publicly.

Neither Vertex Pharmaceuticals nor The National Institutes of Health holds any compliance certifications.

Neither company holds any compliance certifications.

The National Institutes of Health company has more subsidiaries worldwide compared to Vertex Pharmaceuticals company.

The National Institutes of Health company employs more people globally than Vertex Pharmaceuticals company, reflecting its scale as a Biotechnology Research.

Neither Vertex Pharmaceuticals nor The National Institutes of Health holds SOC 2 Type 1 certification.

Neither Vertex Pharmaceuticals nor The National Institutes of Health holds SOC 2 Type 2 certification.

Neither Vertex Pharmaceuticals nor The National Institutes of Health holds ISO 27001 certification.

Neither Vertex Pharmaceuticals nor The National Institutes of Health holds PCI DSS certification.

Neither Vertex Pharmaceuticals nor The National Institutes of Health holds HIPAA certification.

Neither Vertex Pharmaceuticals nor The National Institutes of Health holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Angular is a development platform for building mobile and desktop web applications using TypeScript/JavaScript and other languages. Prior to versions 19.2.16, 20.3.14, and 21.0.1, there is a XSRF token leakage via protocol-relative URLs in angular HTTP clients. The vulnerability is a Credential Leak by App Logic that leads to the unauthorized disclosure of the Cross-Site Request Forgery (XSRF) token to an attacker-controlled domain. Angular's HttpClient has a built-in XSRF protection mechanism that works by checking if a request URL starts with a protocol (http:// or https://) to determine if it is cross-origin. If the URL starts with protocol-relative URL (//), it is incorrectly treated as a same-origin request, and the XSRF token is automatically added to the X-XSRF-TOKEN header. This issue has been patched in versions 19.2.16, 20.3.14, and 21.0.1. A workaround for this issue involves avoiding using protocol-relative URLs (URLs starting with //) in HttpClient requests. All backend communication URLs should be hardcoded as relative paths (starting with a single /) or fully qualified, trusted absolute URLs.

Published
Date
2025-11-26
Updated
Date
2025-11-26
Risk Information
cvss4
Base: 7.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Uncontrolled Recursion vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft deep ASN.1 structures that trigger unbounded recursive parsing. This leads to a Denial-of-Service (DoS) via stack exhaustion when parsing untrusted DER inputs. This issue has been patched in version 1.3.2.

Published
Date
2025-11-26
Updated
Date
2025-11-26
Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Integer Overflow vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft ASN.1 structures containing OIDs with oversized arcs. These arcs may be decoded as smaller, trusted OIDs due to 32-bit bitwise truncation, enabling the bypass of downstream OID-based security decisions. This issue has been patched in version 1.3.2.

Published
Date
2025-11-26
Updated
Date
2025-11-26
Risk Information
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. Prior to versions 7.0.13 and 8.0.2, working with large buffers in Lua scripts can lead to a stack overflow. Users of Lua rules and output scripts may be affected when working with large buffers. This includes a rule passing a large buffer to a Lua script. This issue has been patched in versions 7.0.13 and 8.0.2. A workaround for this issue involves disabling Lua rules and output scripts, or making sure limits, such as stream.depth.reassembly and HTTP response body limits (response-body-limit), are set to less than half the stack size.

Published
Date
2025-11-26
Updated
Date
2025-11-26
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
References
Description

Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. In versions from 8.0.0 to before 8.0.2, a NULL dereference can occur when the entropy keyword is used in conjunction with base64_data. This issue has been patched in version 8.0.2. A workaround involves disabling rules that use entropy in conjunction with base64_data.

Published
Date
2025-11-26
Updated
Date
2025-11-26
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
References